Skip to main content
CB

Corryn Biotechnologies

Corryn Biotechnologies develops the HEALS device, a handheld applicator that utilizes patent-pending electrospinning technology to create a breathable, biodegradable mesh that mimics the natural extracellular matrix for complex wound care. This approach addresses the challenges of chronic wounds by enabling contactless dressing application, reducing pain during treatment, and allowing for tailored material selection at the point of care.

Swansea, United KingdomFounded 20216300+ followers
Updated 20 months ago

Funding

$738.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BD
Funding rounds are not available yet.

Founders

Product

Problem

Chronic wounds present significant challenges due to prolonged healing times, recurrent infections, and substantial pain, leading to frequent medical visits and poor clinical outcomes. Current wound care methods can be painful during dressing application and may not be suitable for all wound scenarios.

Solution

Corryn Biotechnologies offers the HEALS device, a handheld applicator employing electrospinning technology to create a breathable, biodegradable mesh that mimics the natural extracellular matrix for complex wound care. This contactless approach reduces pain during dressing application and allows for tailored material selection at the point of care, ensuring suitability for each wound. The HEALS applicator deposits advanced materials directly onto wounds in a single step, without contacting the patient or dressing material. The advanced materials used in the device improve infection resistance, breathability, and conformity, even over large area wounds.

Target Audience

The primary users are healthcare professionals involved in chronic and complex wound care, including those treating patients with diabetes, pressure sores, and venous leg ulcers.

Features

  • Handheld applicator for contactless wound dressing
  • Electrospinning technology creates a mesh of fine fibers mimicking the natural extracellular matrix
  • Pre-sealed cartridges containing biocompatible, biodegradable synthetic and natural polymers
  • Customizable material selection for individual wound requirements
  • Potential for incorporating active ingredients to combat wound bed infection
  • Breathable and flexible mesh structure with sub-micron pore sizes
  • Reduces pain during dressing application
This profile is AI-generated and may contain inaccuracies.